Single whole-genome sequencing analysis of metastatic biopsy is sufficient for investigational treatment opportunities in cancer
- PMID: 34657396
- PMCID: PMC8696208
- DOI: 10.1002/cac2.12232
Single whole-genome sequencing analysis of metastatic biopsy is sufficient for investigational treatment opportunities in cancer
Conflict of interest statement
The author declares no competing interests.
Comment on
-
Limited evolution of the actionable metastatic cancer genome under therapeutic pressure.Nat Med. 2021 Sep;27(9):1553-1563. doi: 10.1038/s41591-021-01448-w. Epub 2021 Aug 9. Nat Med. 2021. PMID: 34373653
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209‐49. - PubMed
-
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646‐74. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical